Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03131908
Brief Title: Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss

First Submitted : April 24, 2017
First Submitted that Met QC Criteria : April 24, 2017
First Posted : April 27, 2017

Last Update Submitted that Met QC Criteria : January 3, 2020
Last Update Posted : January 6, 2020